Kirin Holdings' Beverage Joint Venture with China Resources Enterprise
Advising Kirin Holdings, a leading Japanese company in the global food and beverage market, in its US$400 million strategic joint venture with China Resources Enterprise, a Hong Kong-based consumer goods company operating in the retail, beer, food and beverage markets throughout China. (2011)
Rakuten's Joint Venture with Baidu, Inc.
Advised Rakuten with respect to its joint venture with Baidu, Inc., the leading Chinese language Internet service provider, to build a online shopping mall for Chinese Internet users. (2010)
Harbin Pharmaceutical’s Landmark Acquisition of Pfizer Business in China
Advised one of the largest pharmaceutical companies in China, Harbin Pharmaceutical, in its asset acquisition of Pfizer’s swine vaccine business in China. This is the first MOFCOM-ordered divestment of its kind. Financial Times refers to this transaction as a "watershed Chinese deal…the first of many such transfers of western IP to Chinese groups arising from local competition rulings." (2010)
6 Waves Inc. Series A Financing
Represented 6 Waves Inc., a leading global developer of entertainment applications and online social games distributor based on Hong Kong, in a corporate restructuring followed by a US$17.5 million Series A Preferred Shares financing from Insight Venture Partners. (2009)
Mount Kellett Capital
Represented Mount Kellett Capital in an undisclosed investment in Asia. (2010)
Carlyle's Investment in iTour International Holdings
Represented Carlyle Asia Growth and other investors in connection with the acquisition of secured convertible notes issued by iTour International Holdings Ltd., one of the leading online travel reservation companies in China. (2009)
Trony Solar Holdings Company Limited's Debt Financing
Represented ICBC International Finance Ltd., as lender, in a US$30 million secured equity-linked debt financing of an affiliate of Trony Solar Holdings Company Limited, a leading thin-film solar product and solution provider utilizing amorphous silicon technology headquartered in China. (2009)
AutoChina International Ltd. Acquisition
Represented AutoChina International Ltd. f/k/a Spring Creek Acquisition Corp., a China-focused special purpose acquisition company (SPAC), in its successful closing of the acquisition of privately held AutoChina Group Inc., a leading one-stop commercial and consumer auto sales and financing company in China. (2009)
Eddingpharm
Advised OrbiMed Advisors and Domain Associates in the initial closing of a US$24 million Series B Preferred Shares financing of Eddingpharm (Cayman) Inc., a leading pharmaceuticals marketing company in China. (2010)
China Investment in Magnesium Company
Represented a global investment bank in connection with a US$42 million investment in a China-based magnesium company.
Multiple Investments for Asia Pacific Capital Fund
Represented venture capital fund, Asia Pacific Capital Fund, as the lead investor in multiple investments including a US$14 million Series B Preferred Shares financing in Access China Holdings Ltd. (Company), which manages Shanghai Storm Information Technology Company Ltd. and a US$120 million Series C Preferred Stock financing for Spudnik Inc. (2009)
China Acquisitions
Represented Avenue Asia with respect to various undisclosed acquisitions of preferred and common shares of companies with operations in China. (2008)
GSR Ventures Investment
Represented GSR Ventures, a leading venture capital fund with operations in Beijing and Silicon Valley, in its investment in a leading Asian casino gaming equipment developer. (2008)
Norwest Venture Partners
Represented a global venture and growth equity investment firm in connection with both its Series A Ordinary Shares financing and follow-on investment in a fabless application-specific integrated circuit (ASIC) company with operations in Shanghai, China. (2009)
Investment Bank's Creation of Special Purpose Financing Vehicle
Represented a major international investment banking firm's private equity arm in an investment in a Hong Kong special purpose vehicle, which in turn acquired certain Philippine and other offshore entities which own and operate a polypropylene plant in the Philippines. (2008)
Merrill Lynch Investment in China Solar Semiconductor Facilities
Represented Merrill Lynch as an arranger of a secured financing facility for an affiliate of a NYSE-listed semiconductor company to fund procurement of thim-film solar semiconductor equipment.
Norwest Venture Partners' Investment in Semiconductor Company
Represented a global venture and growth equity investment firm in connection with both its Series A Ordinary Shares financing and follow-on investment in a fabless ASIC company with operations in Shanghai, China. (2008 and 2009)
China Medical Device Acquisition
Represented a leading China-based medical device company that develops and manufactures advanced in-vitro diagnostic products and ultrasound tumor therapy systems, in its US$345 million acquisition of HPV-DNA Biosensor Chip and Surface Plasmon Resonance based Analysis System for the detection of HPV from a privately held PRC-based company. (2008)
6DXchange Inc. Financing
Represented 6DXchange Inc., a leading B2C e-commerce company based in Shanghai, in a US$10.3 million Series A-1 Preferred Shares financing from affiliates of Baidu, Inc., Qiming Venture Partners, Daphne International Holdings Limited, and certain strategic angel investors. Daphne International Holdings Limited is a leading manufacturer, marketer and distributor of footwear, apparel and accessories. (2009)
Ku6 Holding Limited
Represented Draper Fisher Jurvetson and other investors in connection with the sale of their Preferred Shares in Ku6 Holding Limited, a leading online video portal in China, to NASDAQ-listed Hurray! Holding Company Limited. (2009)
Domain Partners
Advised Domain Partners, a life sciences venture firm based in San Diego and Princeton in connection with a joint venture with Beijing-based firm Elite Consulting to localize and commercialize various healthcare-related technologies in China.
Innovata and Tianjin KingYork Joint Venture
Advised on a transforming and complex joint venture (JV) arrangement between Innovata BioMed, part of the Vectura Group, and Innovata HK Ltd., a Hong Kong-based entity, which has formed a significant mainland China JV with its JV partner Tianjin KingYork Group Co. Ltd., one of the leading pharmaceutical companies in China.
Aspect Gaming
Advised Macau and Shanghai based Aspect Gaming, a supplier of Asian clientele-focused casino gaming content, in its acquisition of Longshot Interactive, a Las Vegas based casino games developer focused on creating Asian-clientele targeted casino games, including a number of proprietary baccarat variants.
ClearVue Partners, L.P.
Represented ClearVue Partners, L.P. on its investment in a Shanghai-based cosmetics start-up founded by a serial entrepreneur that owns and operates one of China's leading collagen-centric beauty product e-commerce platforms.
Themes Investment Management
Represented Themes Investment Management in a staged preferred equity investment in Lonestar Heart Inc., a Texas and California-based biomedical company developing new therapies to preserve and restore adequate heart function in patients with advanced heart failure.
Cathay Capital Holdings II, L.P.
Represented Cathay Capital Holdings II, L.P. in numerous private equity investments in China.